Bumper Offer - Urjas oil Just @ Rs. 1
Dariten OD 7.5 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Urinary Incontinence. Dariten OD 7.5 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Dariten OD 7.5 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Dariten OD 7.5 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Dariten OD 7.5 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Dariten OD 7.5 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Dariten OD 7.5 Tablet related warnings talks about Dariten OD 7.5 Tablet's effects on the liver, heart and kidney.
The section on Dariten OD 7.5 Tablet contraindications lists all such conditions.
Additionally, Dariten OD 7.5 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Dariten OD 7.5 Tablet is considered not safe while driving, and is not addictive.
Dariten OD 7.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Dariten OD 7.5 Tablet is used -
Moderate
Mild
Unknown
Is the use of Dariten OD 7.5 Tablet safe for pregnant women?
Dariten OD may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Dariten OD again without your doctor's advice.
Is the use of Dariten OD 7.5 Tablet safe during breastfeeding?
Dariten OD can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Dariten OD 7.5 Tablet on the Kidneys?
There are no side effects of Dariten OD on the kidneys.
What is the effect of Dariten OD 7.5 Tablet on the Liver?
Very few cases of side effects of Dariten OD on the liver have been reported.
What is the effect of Dariten OD 7.5 Tablet on the Heart?
Dariten OD has very mild side effects on the heart.
Dariten OD 7.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dariten OD 7.5 Tablet unless your doctor advises you to do so -
Is this Dariten OD 7.5 Tablet habit forming or addictive?
Dariten OD 7.5 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Dariten OD 7.5 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Dariten OD 7.5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Dariten OD 7.5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Dariten OD 7.5 Tablet
Taking Dariten OD 7.5 Tablet with food is safe.
Interaction between Alcohol and Dariten OD 7.5 Tablet
Due to lack of research, there is no information about the side effects of taking Dariten OD 7.5 Tablet with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 401
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Enablex® (darifenacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 401
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Enablex® (darifenacin)
